USP10 gene mutations were observed in numerous cancers; therefore, we next explored the potential relationship between the tumor mutational burden (TMB) and USP10 expression in the clinical survival prognosis of different types of cancer (Figure 6B). The gene discussed is USP10; the disease is neoplasm.